Principles of pregnancy management in women with Ph-negative myeloproliferative neoplasms
- Authors: Shmakov R.G.1, Polushkina E.S.1, Akhmedova A.I.1, Sokolova M.A.2, Vinogradova M.A.1
-
Affiliations:
- Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Hematology Research Center, Ministry of Health of Russia
- Issue: No 12 (2017)
- Pages: 46-51
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248052
- DOI: https://doi.org/10.18565/aig.2017.12.46-51
- ID: 248052
Cite item
Abstract
Full Text
About the authors
Roman Georgievich Shmakov
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: r_shmakov@oparina4.ru
MD, chief medical officer
Evgenia Sergeevna Polushkina
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: e_polushkina@oparina4.ru
Ph.D, senior
Aminat Isaevna Akhmedova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_ahmedova@oparina4.ru
postgraduate student
Manana Alexsandrovna Sokolova
Hematology Research Center, Ministry of Health of Russia
Email: s_manana@mail.ru
Ph.D, senior
Maria Alekseevna Vinogradova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: m_vinogradova@oparina4.ru
Ph.D, head of the department of transfusiology and extracorporeal detoxication
References
- Alimam S., Bewley S., Chappell L.C., Knight M., Seed P., Gray G. et al. Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study. Br. J. Haematol. 2016; 175(1): 31-6.
- Lavi N., Horowitz N.A., Brenner B. An update on the management of hematologic malignancies in pregnancy. Womens Health (Lond.). 2014; 10(3): 255-66.
- Skeith L., Carrier M., Robinson S.E., Alimam S., Rodger M.A. Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis. Blood. 2017; 129(8): 934-9.
- Barbui T., Finazzi G., Carobbio A., Thiele J., Passamonti F., Rumi E. et al. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood. 2012; 120(26): 5128-33.
- Rumi E., Bertozzi I., Casetti I.C., Roncoroni E., Cavalloni C., Bellini M. et al.; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators. Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia. Haematologica. 2015; 100(11): e443-5.
- El-Hemaidi I., Robinson S.E. Management of haematological malignancy in pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 2012; 26(1): 149-60.
- Health and Social Care Information Centre (HSCIC). NHS Maternity Statistics -England, 2010-2011.
- Aviles A., Neri N., Nambo M.J. Hematological malignancies and pregnancy: treat or not treat during first trimester. Int. J. Cancer. 2012; 131(11): 2678-83.
- Lavi N., Brenner B., Avivi I. Management of pregnant women with myeloproliferative neoplasms. Thromb. Res. 2013; 131(Suppl. 1): S11-3.
- Umazume T., Yamada T., Akaishi R., Araki N., Nishida R., Morikawa M., Minakami H. Essential thrombocythemia as a risk factor for stillbirth. Thromb. Res. 2014; 133(2): 158-61.
- Gerds A.T., Dao K.H. Polycythemia vera management and challenges in the community health setting. Oncology. 2017; 92(4): 179-89.
- Horowitz N.A., Lavi N., Nadir Y., Brenner B. Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks. Thromb. Haemost. 2016; 16(4): 613-7.
- Pieri L., Guglielmelli P., Vannucchi A.M. Chronic myeloproliferative neoplasms: a collaborative approach. Mediterr. J. Hematol. Infect. Dis. 2010; 2(2): e2010017.
- Gangat N., Wolanskyj A.P., Schwager S., Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. Eur. J. Haematol. 2009; 82(5): 350-3.
- Сухих Г.Т., Давыдов М.И., Савченко В.Г. Репродуктивное здоровье женщин с онкогематологическими заболеваниями. М.; 2012: 172-8. [Sukhikh G.T., Davydov M.I., Savchenko V.G. Reproductive health of women with oncohematological diseases. Moscow; 2012: 172-8. (in Russian)]
- Amit O., Barzilai M., Avivi I. Management of hematologic malignancies: special considerations in pregnant women. Drugs. 2015; 75(15): 1725-38.
- Barbui T., Barosi G., Birgegard G., Cervantes F., Finazzi G., Griesshammer M. et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukaemiaNet. J. Clin. Oncol. 2011; 29(6): 761-70.
- Yazdani Brojeni P., Matok I., Garcia Bournissen F., Koren G. A systematic review of the fetal safety of interferon alpha. Reprod. Toxicol. 2012; 33(3): 265-8.